Markets are quite bad at developing any kind of reserves. So in the case of antibiotics: we have the antibiotics we need at the moment ( at least mostly). A new

Markets are quite bad at developing any kind of reserves. So in the case of antibiotics: we have the antibiotics we need at the moment ( at least mostly). A new antibiotic would be quite expensive to develop, and then it would just sit on a shelf. Thinking about it, it is quite the same as the banking crisis in 2008, there was no secondary banking system, because that would operate at higher cost and therefore get kicked out of the market.